During the past decade, LLC Mart conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LLC Mart" are "Coronary Heart Disease (CHD)" (1 trials) and "Discogenic Pain" (1 trials). Many other conditions were trialed in "LLC Mart" in a lesser frequency.

Most popular intervention types in "LLC Mart" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Evolocumab" (1 trials), "STA363 containing 180 mg (120 mg/mL) lactic acid" (1 trials) and "STA363 containing 90 mg (60 mg/mL) lactic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "LLC Mart" are 2 trials for "All" genders.

Currently, there are NaN active trials in "LLC Mart". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in LLC Mart, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LLC Mart, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".